125 results
8-K
EX-99.1
BIOCQ
Biocept Inc
22 Aug 23
Biocept Reports Second Quarter 2023 Financial Results
4:10pm
, with the decrease primarily due to a reduction in headcount and lower purchases of materials and supplies.
General and administrative (G&A) expenses
8-K
EX-99.1
BIOCQ
Biocept Inc
15 May 23
Biocept Reports First Quarter 2023 Financial Results
6:07am
and lower purchases of materials and supplies.
General and administrative expenses for the first quarter of 2023 were $3.0 million, compared with $6.3
DEFR14A
kftun5tawq
21 Apr 23
Revised proxy
8:30am
8-K
EX-99.1
8flo2ig6fai9g3y 4bq
17 Apr 23
Biocept Reports 2022 Financial Results
4:46pm
8-K
o1d0hpcp3 ha
14 Jul 22
Regulation FD Disclosure
6:07am
DEFA14A
fpj21agea
27 Jun 22
Additional proxy soliciting materials
4:08pm
DEFA14A
sn6j553 74tm39yplpua
13 Jun 22
Additional proxy soliciting materials
4:05pm